from Reuters: U.S. https://ift.tt/2rLi1qj
Thursday, 20 December 2018
Home »
news
,
Reuters US
,
Reuters US news
,
Reuters: U.S.
» U.S. agency recommends opioid overdose antidote to high-risk patients
U.S. agency recommends opioid overdose antidote to high-risk patients
The U.S. Department of Health and Human Services (HHS) on Wednesday recommended prescribing or co-prescribing the opioid overdose reversal drug, naloxone, to high-risk patients.

from Reuters: U.S. https://ift.tt/2rLi1qj
from Reuters: U.S. https://ift.tt/2rLi1qj
Related Posts:
Manafort seeks sentence well below guidelines in Virginia caseLawyers for Paul Manafort, U.S. President Donald Trump's former campaign chairman, asked a federal judge in Virginia on Friday to hand down a sentence that is significantly below sentencing guidelines, according to a court fi… Read More
Warmbier parents blast 'evil' North Korea regime after Trump praises KimThe parents of Otto Warmbier, an American student who died after 17 months in a North Korean prison, blamed Kim Jong Un's "evil regime" on Friday after U.S. President Donald Trump said he believed the leader's claim not to ha… Read More
Warmbier parents blast 'evil' North Korea regime after Trump praises KimThe parents of Otto Warmbier, an American student who died after 17 months a North Korean prison, blamed Kim Jong Un's "evil regime" on Friday after U.S. President Donald Trump said he believed the leader's claim not to have … Read More
Texas cargo plane's cockpit voice recorder recovered in fatal crashThe U.S. National Transportation Safety Board said on Friday that investigators have recovered the cockpit voice recorder from a cargo plane that crashed on Feb. 23 in Texas, killing three. from Reuters: U.S. https://ift… Read More
SpaceX to launch capsule to space station in key milestoneElon Musk's SpaceX was due to launch an unmanned crew capsule atop a Falcon 9 rocket early on Saturday bound for the International Space Station, a major step toward NASA's goal of reviving the U.S. human spaceflight program … Read More
0 comments:
Post a Comment